Xenetic Biosciences (XBIO) Announces Favorable Data from Third Cohort of ErepoXen Phase 3 in Anemia
Go back to Xenetic Biosciences (XBIO) Announces Favorable Data from Third Cohort of ErepoXen Phase 3 in Anemia| Xenetic Biosciences, Inc. (NASDAQ: XBIO) | Delayed: 3.85 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.85 | 52 Week High | $5.20 | |||
| Open | $3.85 | 52 Week Low | $0.21 | |||
| Day High | $3.85 | P/E | N/A | |||
| Day Low | $3.85 | EPS | $-0.01 | |||
| Volume | 537 | |||||
